Shopping Cart 0
Cart Subtotal
AED 0

Shimadzu Corp (7701) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Shimadzu Corp (Shimadzu) is a manufacturer of precision instruments, measuring instruments and medical equipment. The company's product portfolio includes high performance liquid chromatographs (HPLC), spectrometers, carbon analyzer, X-ray systems, inspection systems, semiconductor manufacturing equipment, liquid transmission equipment, hydraulic equipment, onboard flight management systems, flight control systems, and cockpit display systems. Shimadzu offers products to wide range of industries such as healthcare (hospitals and clinics), pharmaceutical, chemical, aeronautic, food and beverages, education, construction and other industries. The company along with its subsidiaries markets products through a network of distributors in the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Shimadzu is headquartered in Kyoto, Japan.

Shimadzu Corp (7701)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Shimadzu Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Shimadzu Corp, Medical Devices Deals, 2012 to YTD 2018 10

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Shimadzu Corp, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Shimadzu Scientific to Enter into Agreement with Cure Pharmaceutical and CK Science 12

Licensing Agreements 13

HuniLife Biotech Receives Rights for Lactosome from Shimadzu 13

Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 14

Acquisition 15

Shimadzu Acquires AlsaChim 15

Shimadzu Corp-Key Competitors 16

Shimadzu Corp-Key Employees 17

Shimadzu Corp-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Joint Venture 20

Recent Developments 21

Strategy And Business Planning 21

Jul 03, 2018: Launch of Shimadzu European Innovation Center 21

Nov 17, 2017: Shimadzu Promotes the Creation of Products Using KeyTechnologies Through Joint Research and DevelopmentInnovation Centre in Singapore in Operation 22

Product News 23

Dec 06, 2017: New C2MAP Automated Pretreatment Module for Cell Culture Media Analysis Automates Processes from Pretreatment to Measurement 23

Nov 30, 2017: Shimadzu's New TD-30 Series of Thermal Desorption Systems for Gas Chromatographs and GCMS Systems Provides Accurate Analysis of Volatile Compounds 24

Nov 28, 2017: Shimadzu's New MALDI-8020 MALDI-TOF Mass Spectrometer Offers the World's Highest Level of Analytical Performance in a Benchtop Model 25

Oct 24, 2017: IRSpirit FTIR spectrophotometers-Smalles footprint meets exceptional ease of use functionality 26

Oct 05, 2017: Shimadzu's New Compact Fourier Transform Infrared (FTIR) Spectrophotometers Offer Exceptional Ease-of-Use and Functionality 28

Sep 22, 2017: Shimadzu's New i-Series Plus Integrated High-Performance Liquid Chromatograph Significantly Improves Analytical Productivity with Automated Pretreatment Operations 29

Sep 21, 2017: Shimadzu's New DPiMS-2020 Probe Electrospray Ionization Mass Spectrometer Offers Quick Measurement Without Pretreatment 30

Aug 30, 2017: Shimadzu's New EDX-8100 Energy Dispersive X-Ray Fluorescence Spectrometer Enables Analysis of Liquid Samples with High Sensitivity by Helium Purging 31

Jun 04, 2018: Shimadzu Collaborates with PREMIER Biosoft to Launch the LCMS-9030 Q-TOF Platform for Comprehensive Lipid and Glycan Analysis 32

Jan 29, 2018: Shimadzu's New Nexera Mikros, a Micro Flowrate Compatible Liquid Chromatograph Mass Spectrometer, Provides the Pharmaceutical Industry with High Sensitivity, Durability, and Ease of Use 33

Other Significant Developments 34

Sep 13, 2017: Updated LabSolutions software Supplementary data integrity functions added for the pharmaceutical industry 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Shimadzu Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Shimadzu Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Shimadzu Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Shimadzu Corp, Deals By Therapy Area, 2012 to YTD 2018 9

Shimadzu Corp, Medical Devices Deals, 2012 to YTD 2018 10

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Shimadzu Scientific to Enter into Agreement with Cure Pharmaceutical and CK Science 12

HuniLife Biotech Receives Rights for Lactosome from Shimadzu 13

Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 14

Shimadzu Acquires AlsaChim 15

Shimadzu Corp, Key Competitors 16

Shimadzu Corp, Key Employees 17

Shimadzu Corp, Other Locations 18

Shimadzu Corp, Subsidiaries 19

Shimadzu Corp, Joint Venture 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Shimadzu Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Shimadzu Corp (Shimadzu) is a manufacturer of precision instruments, measuring instruments and medical equipment. The company's product portfolio includes high performance liquid chromatographs (HPLC), spectrometers, carbon analyzer, X-ray systems, inspection systems, semiconductor manufacturing equipment, liquid transmission equipment, hydraulic equipment, onboard flight management systems, flight control systems, and cockpit display systems. Shimadzu offers products to wide range of industries such as healthcare (hospitals and clinics), pharmaceutical, chemical, aeronautic, food and beverages, education, construction and other industries. The company along with its subsidiaries markets products through a network of distributors in the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Shimadzu is headquartered in Kyoto, Japan.

Shimadzu Corp (7701)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Shimadzu Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Shimadzu Corp, Medical Devices Deals, 2012 to YTD 2018 10

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Shimadzu Corp, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Shimadzu Scientific to Enter into Agreement with Cure Pharmaceutical and CK Science 12

Licensing Agreements 13

HuniLife Biotech Receives Rights for Lactosome from Shimadzu 13

Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 14

Acquisition 15

Shimadzu Acquires AlsaChim 15

Shimadzu Corp-Key Competitors 16

Shimadzu Corp-Key Employees 17

Shimadzu Corp-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Joint Venture 20

Recent Developments 21

Strategy And Business Planning 21

Jul 03, 2018: Launch of Shimadzu European Innovation Center 21

Nov 17, 2017: Shimadzu Promotes the Creation of Products Using KeyTechnologies Through Joint Research and DevelopmentInnovation Centre in Singapore in Operation 22

Product News 23

Dec 06, 2017: New C2MAP Automated Pretreatment Module for Cell Culture Media Analysis Automates Processes from Pretreatment to Measurement 23

Nov 30, 2017: Shimadzu's New TD-30 Series of Thermal Desorption Systems for Gas Chromatographs and GCMS Systems Provides Accurate Analysis of Volatile Compounds 24

Nov 28, 2017: Shimadzu's New MALDI-8020 MALDI-TOF Mass Spectrometer Offers the World's Highest Level of Analytical Performance in a Benchtop Model 25

Oct 24, 2017: IRSpirit FTIR spectrophotometers-Smalles footprint meets exceptional ease of use functionality 26

Oct 05, 2017: Shimadzu's New Compact Fourier Transform Infrared (FTIR) Spectrophotometers Offer Exceptional Ease-of-Use and Functionality 28

Sep 22, 2017: Shimadzu's New i-Series Plus Integrated High-Performance Liquid Chromatograph Significantly Improves Analytical Productivity with Automated Pretreatment Operations 29

Sep 21, 2017: Shimadzu's New DPiMS-2020 Probe Electrospray Ionization Mass Spectrometer Offers Quick Measurement Without Pretreatment 30

Aug 30, 2017: Shimadzu's New EDX-8100 Energy Dispersive X-Ray Fluorescence Spectrometer Enables Analysis of Liquid Samples with High Sensitivity by Helium Purging 31

Jun 04, 2018: Shimadzu Collaborates with PREMIER Biosoft to Launch the LCMS-9030 Q-TOF Platform for Comprehensive Lipid and Glycan Analysis 32

Jan 29, 2018: Shimadzu's New Nexera Mikros, a Micro Flowrate Compatible Liquid Chromatograph Mass Spectrometer, Provides the Pharmaceutical Industry with High Sensitivity, Durability, and Ease of Use 33

Other Significant Developments 34

Sep 13, 2017: Updated LabSolutions software Supplementary data integrity functions added for the pharmaceutical industry 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Shimadzu Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Shimadzu Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Shimadzu Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Shimadzu Corp, Deals By Therapy Area, 2012 to YTD 2018 9

Shimadzu Corp, Medical Devices Deals, 2012 to YTD 2018 10

Shimadzu Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Shimadzu Scientific to Enter into Agreement with Cure Pharmaceutical and CK Science 12

HuniLife Biotech Receives Rights for Lactosome from Shimadzu 13

Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 14

Shimadzu Acquires AlsaChim 15

Shimadzu Corp, Key Competitors 16

Shimadzu Corp, Key Employees 17

Shimadzu Corp, Other Locations 18

Shimadzu Corp, Subsidiaries 19

Shimadzu Corp, Joint Venture 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Shimadzu Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.